Pediatri Uzman ve Asistanlarının Astım İlaçları Hakkındaki Bilgi Düzeyinin Değerlendirilmesi

Background/Objectives:Asthma is the most common chronic respiratory disease in childhood, with a rising prevalence both worldwide and in Türkiye. Around 70–80% of pediatric asthma cases are allergic. Despite the presence of established guidelines, knowledge gaps and practice inconsistencies remain. This study aimed to compare the knowledge levels of pediatric specialists and residents regarding asthma treatment.Methods:This cross-sectional study was conducted in February–March 2025 at the University of Health Sciences Ümraniye Training and Research Hospital. Pediatric specialists and residents completed a 31-item questionnaire based on the 2024 GINA guidelines, including 25 questions on asthma management. Each correct answer was scored as 4 points. Statistical analyses were performed using SPSS 22 with Chi-square/Fisher’s exact tests for categorical and independent t test/Mann–Whitney U for continuous variables. A p value <0.05 was considered significant. Ethical approval was obtained (26.12.2024; no. 470).Results:A total of 53 physicians participated (15 specialists, 38 residents). Specialists had longer experience (≥7 years: 73.3%), whereas most residents had 1–3 years (84.2%). Asthma training was reported more frequently among specialists (86.7% vs. 44.7%). While overall scores were similar, differences emerged: all specialists recognized spacer efficacy (100% vs. 76.3%, p=0.039), whereas residents more often identified omalizumab for allergic asthma (89.5% vs. 53.3%, p=0.003) and budesonide/fluticasone as first-line therapy (94.7% vs. 73.3%, p=0.027).Conclusions:Specialists showed stronger knowledge of inhaler devices, whereas residents were more updated on biologics and pharmacotherapy. Tailored educational strategies may enhance standardized, evidence-based pediatric asthma care.